A Phase 2a, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Trial Profile

A Phase 2a, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Completed
Phase of Trial: Phase II

Latest Information Update: 28 May 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Plantar fasciitis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Revance Therapeutics
  • Most Recent Events

    • 19 Apr 2018 Results published in the Revance Therapeutics Media Release
    • 19 Apr 2018 According to a Revance Therapeutics ,Status changed from active, no longer recruiting to completed.
    • 08 Jan 2018 Results presented in a Revance Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top